Low-molecular-weight heparin-conjugated liposomes with improved stability and hemocompatibility

被引:3
|
作者
Köse, GT [1 ]
Arica, MY [1 ]
Hasirci, V [1 ]
机构
[1] Middle E Tech Univ, Dept Biol Sci, Biotechnol Res Unit, TR-06531 Ankara, Turkey
关键词
conjugation; hemocompatibility; liposome stability; low molecular weight heparin; multilamellar liposome;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Multilamellar vesicles (MLV) containing phosphatidyl choline (PC), cholestrol (CHOL), and stearylamine (SA) in the molar ratio of 7:2:0.2 were prepared by the thin film hydration method. Low-molecular-weight heparin (LMWH, MW: 3000) was conjugated with the MLV using carbodiimide (EDC), Infrared, Raman, and nuclear magnetic resonance spectra and DSC of each sample (MLV, LMWH, and MLV-LMWH) were obtained, enabling the authors to determine the chemical changes that occurred in the MLV structure at the end of the conjugation step. In addition, the changes in the chemical structures of the conjugated samples were revealed by the use of elemental analysis. Particle size analysis was used to determine the difference between the sizes of MLV and MLV-LMWH. In order to study the effect of LMWH on the behavior of MLV-LMWH in blood, osmotic fragility (in saline and plasma), hemolytic activity, and plasma recalcification time tests were carried out. These tests showed that it was possible to construct liposomes that would not induce reactions in the blood and would have potentially longer half-lives in the circulation.
引用
收藏
页码:257 / 264
页数:8
相关论文
共 50 条
  • [1] Heparin and low-molecular-weight heparin
    Gray, Elaine
    Mulloy, Barbara
    Barrowcliffel, Trevor W.
    THROMBOSIS AND HAEMOSTASIS, 2008, 99 (05) : 807 - 818
  • [2] Low-molecular-weight heparin in oncology
    Zacharski, LR
    Loynes, JT
    ANTICANCER RESEARCH, 2003, 23 (3C) : 2789 - 2793
  • [3] Low-molecular-weight heparin for thromboprophylaxis
    Camporese, Giuseppe
    Bernardi, Enrico
    CURRENT OPINION IN PULMONARY MEDICINE, 2009, 15 (05) : 443 - 454
  • [4] Topical delivery of low-molecular-weight heparin with surface-charged flexible liposomes
    Song, YK
    Kim, CK
    BIOMATERIALS, 2006, 27 (02) : 271 - 280
  • [5] Low-molecular-weight heparin during pregnancy
    Bazzan, M
    Donvito, V
    THROMBOSIS RESEARCH, 2001, 101 (01) : V175 - V186
  • [6] Improved cancer mortality with low-molecular-weight heparin treatment: A review of the evidence
    Cosgrove, RH
    Zacharski, LR
    Racine, E
    Andersen, JC
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2002, 28 (01) : 79 - 87
  • [7] COMPARISON OF LOW-MOLECULAR-WEIGHT HEPARIN VS UNFRACTIONATED HEPARIN IN GYNECOLOGICAL SURGERY .2. REDUCED DOSE OF LOW-MOLECULAR-WEIGHT HEPARIN
    BORSTAD, E
    URDAL, K
    HANDELAND, G
    ABILDGAARD, U
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1992, 71 (06) : 471 - 475
  • [8] Heparin and low-molecular-weight heparin in the treatment of venous thromboembolism
    Pineo, GF
    Hull, RD
    BAILLIERES CLINICAL HAEMATOLOGY, 1998, 11 (03): : 621 - 637
  • [9] Localization of heparin and low-molecular-weight heparin in the rat kidney
    Young, E
    Douros, V
    Podor, TJ
    Shaughnessy, SG
    Weitz, JI
    THROMBOSIS AND HAEMOSTASIS, 2004, 91 (05) : 927 - 934
  • [10] Portable Compression Device and Low-Molecular-Weight Heparin Compared With Low-Molecular-Weight Heparin for Thromboprophylaxis After Total Joint Arthroplasty
    Edwards, John Z.
    Pulido, Pamela A.
    Ezzet, Kace A.
    Copp, Steven N.
    Walker, Richard H.
    Colwell, Clifford W., Jr.
    JOURNAL OF ARTHROPLASTY, 2008, 23 (08) : 1122 - 1127